1. Home
  2. News
  3. Nanjing Well Pharmaceutical Group Co. Ltd.
  4. Announcement on Risk Warning in Stock Trading
More Nanjing Well Pharmaceutical Group Co. Ltd. news
Nanjing Well Pharmaceutical Group Co. Ltd.SSE: 603351

Announcement on Risk Warning in Stock Trading

Apr 23, 2025 · Issued by Nanjing Well Pharmaceutical Group Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 23, 2025 · 2 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-risk-warning-in-stock-trading-200

Nanjing Well Pharmaceutical Group Co. Ltd. on 6ix

Earlier from Nanjing Well Pharmaceutical

  • 2024 Annual ReportApr 22, 2025
  • Announcement on Pledge of Shares Held by Controlling ShareholderMar 26, 2025
  • Announcement on the Re-certification of Wholly-owned Subsidiary as High-Tech EnterpriseFeb 7, 2025
  • Announcement on Early Release of Pledge of Controlling Shareholder's SharesJan 15, 2025
  • Announcement on the Extension of Share Pledge for Shareholders Holding More Than 5% of SharesJan 10, 2025

Later from Nanjing Well Pharmaceutical

  • Announcement on Convening the 2024 Annual and Q1 2025 Performance BriefingApr 30, 2025
  • Announcement on Resolutions of the 2024 Annual General MeetingMay 16, 2025
  • Announcement on Implementation of Dividend Distribution for 2024Jun 6, 2025
  • Announcement on Pledge and Release of Pledge of Shares of Shareholder with Over 5% SharesAug 19, 2025
  • 2025 Semi-annual ReportAug 20, 2025
All Nanjing Well Pharmaceutical news releases↗

Follow Nanjing Well Pharmaceutical into a list and get an email when it puts out news.

Follow Nanjing Well Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer